Meeting
2016 Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy alone with mFOLFOXIRI in locally advanced rectal cancer: A single-arm phase II study.
Authors
Yanhong Deng
Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Yanhong Deng , Jianwei Zhang , Yue Cai , Huabin Hu , Jiayu Ling , Jian Xiao , Meijin Huang , Liang Kang , Lei Wang , Ping Lan , Jianping Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT02217020
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr TPS783)
DOI
10.1200/jco.2016.34.4_suppl.tps783
Abstract #
TPS783
Poster Bd #
O14
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.
First Author: Wen Zhang
Poster
2018 ASCO Annual Meeting
Total neoadjuvant treatment versus chemoradiotherapy in locally advanced rectal cancer: A propensity score analysis from two prospective phase II clinical trials.
First Author: Jianwei Zhang
Poster
2017 ASCO Annual Meeting
Neoadjuvant chemotherapy with mFOLFOXIRI alone for cT4 and fixed cT3 rectal cancer: Results from a single arm phase II study (FORTUNE).
First Author: Jianwei Zhang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.
First Author: Meng Wang